Clearance Summary
ENCORE 26 ADVANTAGE KIT received FDA 510(k) clearance under submission number K123214, sponsored by Boston Scientific Corp. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2012-11-13.
- Submission: K123214
- Applicant / Sponsor: Boston Scientific Corp
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1650
- Decision date: 2012-11-13
Classification & Regulation
This clearance is catalogued under FDA product code MAV and 21 CFR 870.1650, within the Cardiovascular review panel as a Class II device.